Northwest Biotherapeutics (NWBO) Cash & Equivalents (2010 - 2026)
Northwest Biotherapeutics (NWBO) posted Cash & Equivalents of $595,000 for Q2 2026, down 86.2% from $4.32 million a year earlier and down 66.7% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Northwest Biotherapeutics' Cash & Equivalents came in at $3.04 million, up 39.8% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
- In prior years, Northwest Biotherapeutics' Cash & Equivalents was $2.18 million in FY2024 (+2.3%), $2.13 million in FY2023 (-69.5%), $6.97 million in FY2022 (-54.1%) and $15.17 million in FY2021 (+51.9%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q4 2019.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with an average decline of 1.8%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2022, with growth of 145.7%; the weakest was Q2 2026, with a decline of 86.2%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $1.79 million (Q1 2026), $3.04 million (Q4 2025) and $4.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | 595,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 595,000.00 |
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 6.19 Mn |
| Dec 31, 2022 | 6.97 Mn |
| Sep 30, 2022 | 9.43 Mn |
| Jun 30, 2022 | 4.83 Mn |
| Mar 31, 2022 | 6.96 Mn |
| Dec 31, 2021 | 15.17 Mn |
| Sep 30, 2021 | 3.84 Mn |
API Access
Northwest Biotherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();